AGAcell® on «La Vanguardia»: Ideeea Therapeutics’ Bet on Androgenetic Alopecia

A therapy based on adipose tissue–derived stem cells combined with adenosine triphosphate has demonstrated its effectiveness in reversing the effects of androgenetic alopecia in an experiment conducted in mice, led by researchers from the Department of Dermatology at Hospital Clínico San Carlos in Madrid. The study, published in Stem Cell Research & Therapy, evaluated the efficacy […]

AGAcell® on «La Razón»: A Spanish hospital uses stem cells to treat alopecia

A Spanish hospital uses stem cells to treat alopecia Dermatologists at Hospital Clínico San Carlos in Madrid are conducting research using mesenchymal stem cells to treat androgenetic alopecia, the most prevalent form of hair loss. Androgenetic alopecia, also known as common baldness, is a dynamic and progressive hair loss disorder that affects both men and […]

AGAcell® on «El Español»:In four years, we could have a stem cell therapy to end baldness.

In four years, we could have a stem cell therapy to end baldness. A stem cell‑based therapy has succeeded in regenerating the hair of mice with induced androgenetic alopecia. The breakthrough comes from a Spanish research team led by Dr. Eduardo López Bran, Head of Dermatology at Hospital Clínico San Carlos in Madrid. López Bran and his colleagues extracted stem cells from adipose (fat) tissue, cultured […]

AGAcell® on «RTVE»:A Spanish Study Brings the End of Alopecia Closer

A Spanish Study Brings the End of Alopecia Closer Spanish scientists have set a five-year horizon to potentially put an end to alopecia, following a study conducted at the Hospital Clínico San Carlos in Madrid and recently published in the journal Stem Cell Research & Therapy. The key to success—so far demonstrated in mice—lies in a […]

«El Confidencial»: Ideeea Therapeutics announces AGAcell®: An allogeneic cell therapy program in preclinical development for alopecia.

Ideeea Therapeutics announces AGAcell®: an allogeneic cell therapy program in preclinical development for alopecia. Ideeea Therapeutics closes €2.3 million seed round to advance the development of advanced therapy medicinal products with an open science and high clinical impact approach. AGAcell® is a preclinical research program that explores the use of allogeneic mesenchymal stem cells for […]